Pharma BD Deal Intelligence
Reig Jofre expands outside of Spain with Bioglan acquisition gaining Swedish pharmaceutical dermatological manufacturing capabilities
Simon Bjorklund CEO of Bioglan Sweden discusses company operations under Reig Jofre ownership and dermatological pharmaceutical manufacturing
Reig Jofre corporate history documents 2009 acquisition of Swedish company Bioglan AB as first step in international expansion beyond Spain
Source summaries from our enrichment pipeline; follow links for originals.
All 10 sources with sentiment breakdown →
Spanish pharmaceutical group Reig Jofre acquired Bioglan AB, a Swedish dermatology-focused pharmaceutical manufacturer, in 2009 for an undisclosed sum. The acquisition was Reig Jofre's first step in international expansion beyond Spain and added Swedish dermatological manufacturing capabilities.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Reig Jofre / Bioglan (this deal) | 2009 | — | 48 |
| Astellas Pharma Inc. / Seagen Inc. | 2009 | $4.5B | 95 |
| Bristol-Myers Squibb Company / Medarex Inc. | 2009 | $2.4B | 92 |
| Johnson & Johnson / Cougar Biotechnology, Inc. | 2009 | $970M | 91 |
| Pfizer Inc. / Wyeth | 2009 | $68.0B | 86 |
| QIAGEN N.V. / DxS Ltd. | 2009 | $130M | 85 |
| Sigma-Tau Group / Enzon Pharmaceuticals (Specialty Pharma business) | 2009 | $327M | 85 |
← Browse all deals · How we score deals
More: 2009 deals